Cargando…

Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function

The aim of the present study was to analyze the profiles of cardiac microRNAs (miRNAs/miRs) in healthy pregnant women and non-pregnant controls. A total of 61 healthy women >18 years of age with singleton pregnancies in the third trimester were compared with 19 non-pregnant controls. Specifically...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczerba, Ewa, Zajkowska, Agnieszka, Bochowicz, Anna, Pankiewicz, Katarzyna, Szewczyk, Grzegorz, Opolski, Grzegorz, Maciejewski, Tomasz, Małecki, Maciej, Fijałkowska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469559/
https://www.ncbi.nlm.nih.gov/pubmed/32934814
http://dx.doi.org/10.3892/br.2020.1348
_version_ 1783578435914825728
author Szczerba, Ewa
Zajkowska, Agnieszka
Bochowicz, Anna
Pankiewicz, Katarzyna
Szewczyk, Grzegorz
Opolski, Grzegorz
Maciejewski, Tomasz
Małecki, Maciej
Fijałkowska, Anna
author_facet Szczerba, Ewa
Zajkowska, Agnieszka
Bochowicz, Anna
Pankiewicz, Katarzyna
Szewczyk, Grzegorz
Opolski, Grzegorz
Maciejewski, Tomasz
Małecki, Maciej
Fijałkowska, Anna
author_sort Szczerba, Ewa
collection PubMed
description The aim of the present study was to analyze the profiles of cardiac microRNAs (miRNAs/miRs) in healthy pregnant women and non-pregnant controls. A total of 61 healthy women >18 years of age with singleton pregnancies in the third trimester were compared with 19 non-pregnant controls. Specifically, expression of miRNAs associated with cardiac hypertrophy (miR-1, miR-17-5, miR-22, miR-34a, miR-124, miR-133a, miR-195, miR-199a-3p, miR-199b, miR-210, miR-222 and miR-1249) and miRNAs associated with cardiac hypertrophy and fibrosis (miR-15b, miR-21, miR-26a, miR-29-a, miR-29c, miR-30c, miR-101, miR-146a, miR-191, miR-208a-5p and miR-328) were analyzed and compared with echocardiographic examination results. Both groups had similar cardiac miRNA expression profiles, but differed in quantitative evaluation. Women in the third trimester of physiological pregnancy exhibited downregulation of certain profibrotic miRNAs (miR-21, miR-30c and miR-328), decreased expression of a hypertrophic and antimetabolic miRNAs (miR-146a), downregulation of an antifibrotic miRNA (miR-222), and downregulation of a hypertrophic miRNA (miR-195). In pregnant women, the indices of systolic function were associated with miR-195 expression, and an interplay between miR-17-5p and diastolic function was observed. While the profiles of cardiac miRNAs expressed in healthy pregnant women and healthy non-pregnant controls were similar, these two groups differed in terms of expression of specific miRNAs. In the third trimester of physiological pregnancy, a downregulation of miR-17-5p, miR-21, miR-30c, miR-146a, miR-195, miR-222 and miR-328 was observed. The differences in the association between echocardiographic indices with miRNAs in pregnant and non-pregnant women suggest that miRNAs regulate both the structure and function of the pregnant heart, influencing cardiac muscle thickness as well as systolic and diastolic function.
format Online
Article
Text
id pubmed-7469559
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-74695592020-09-14 Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function Szczerba, Ewa Zajkowska, Agnieszka Bochowicz, Anna Pankiewicz, Katarzyna Szewczyk, Grzegorz Opolski, Grzegorz Maciejewski, Tomasz Małecki, Maciej Fijałkowska, Anna Biomed Rep Articles The aim of the present study was to analyze the profiles of cardiac microRNAs (miRNAs/miRs) in healthy pregnant women and non-pregnant controls. A total of 61 healthy women >18 years of age with singleton pregnancies in the third trimester were compared with 19 non-pregnant controls. Specifically, expression of miRNAs associated with cardiac hypertrophy (miR-1, miR-17-5, miR-22, miR-34a, miR-124, miR-133a, miR-195, miR-199a-3p, miR-199b, miR-210, miR-222 and miR-1249) and miRNAs associated with cardiac hypertrophy and fibrosis (miR-15b, miR-21, miR-26a, miR-29-a, miR-29c, miR-30c, miR-101, miR-146a, miR-191, miR-208a-5p and miR-328) were analyzed and compared with echocardiographic examination results. Both groups had similar cardiac miRNA expression profiles, but differed in quantitative evaluation. Women in the third trimester of physiological pregnancy exhibited downregulation of certain profibrotic miRNAs (miR-21, miR-30c and miR-328), decreased expression of a hypertrophic and antimetabolic miRNAs (miR-146a), downregulation of an antifibrotic miRNA (miR-222), and downregulation of a hypertrophic miRNA (miR-195). In pregnant women, the indices of systolic function were associated with miR-195 expression, and an interplay between miR-17-5p and diastolic function was observed. While the profiles of cardiac miRNAs expressed in healthy pregnant women and healthy non-pregnant controls were similar, these two groups differed in terms of expression of specific miRNAs. In the third trimester of physiological pregnancy, a downregulation of miR-17-5p, miR-21, miR-30c, miR-146a, miR-195, miR-222 and miR-328 was observed. The differences in the association between echocardiographic indices with miRNAs in pregnant and non-pregnant women suggest that miRNAs regulate both the structure and function of the pregnant heart, influencing cardiac muscle thickness as well as systolic and diastolic function. D.A. Spandidos 2020-11 2020-08-27 /pmc/articles/PMC7469559/ /pubmed/32934814 http://dx.doi.org/10.3892/br.2020.1348 Text en Copyright: © Szczerba et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Szczerba, Ewa
Zajkowska, Agnieszka
Bochowicz, Anna
Pankiewicz, Katarzyna
Szewczyk, Grzegorz
Opolski, Grzegorz
Maciejewski, Tomasz
Małecki, Maciej
Fijałkowska, Anna
Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function
title Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function
title_full Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function
title_fullStr Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function
title_full_unstemmed Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function
title_short Downregulated expression of microRNAs associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function
title_sort downregulated expression of micrornas associated with cardiac hypertrophy and fibrosis in physiological pregnancy and the association with echocardiographically-evaluated myocardial function
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469559/
https://www.ncbi.nlm.nih.gov/pubmed/32934814
http://dx.doi.org/10.3892/br.2020.1348
work_keys_str_mv AT szczerbaewa downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT zajkowskaagnieszka downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT bochowiczanna downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT pankiewiczkatarzyna downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT szewczykgrzegorz downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT opolskigrzegorz downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT maciejewskitomasz downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT małeckimaciej downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction
AT fijałkowskaanna downregulatedexpressionofmicrornasassociatedwithcardiachypertrophyandfibrosisinphysiologicalpregnancyandtheassociationwithechocardiographicallyevaluatedmyocardialfunction